None
Quote | Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)
Last: | $22.33 |
---|---|
Change Percent: | 0.0% |
Open: | $22.33 |
Close: | $22.33 |
High: | $22.33 |
Low: | $22.33 |
Volume: | 204 |
Last Trade Date Time: | 04/17/2024 03:00:00 am |
News | Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)
2024-04-12 13:30:00 ET Summary The list ranks stocks based on their market cap and dividend yield alone. What I am looking for is quality dividend stocks with long track records of progressive dividend growth, and while dividend yield is still important, it's a secondary considera...
2024-02-23 10:21:45 ET More on Hikma Pharmaceuticals Hikma Pharmaceuticals PLC (HKMPF) Q4 2023 Earnings Call Transcript Historical earnings data for Hikma Pharmaceuticals Dividend scorecard for Hikma Pharmaceuticals Financial information for Hikma Pharmaceuti...
Message Board Posts | Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)
Subject | By | Source | When |
---|---|---|---|
Stock_Tracker: Latest Hikma Pharmaceutical (HKMPF) Headlines Injectable Generic and Biosimilar Drugs | Stock_Tracker | investorshangout | 03/10/2014 7:25:14 AM |
chartguy89: HKMPF 23.6363 Stock Charts $HKMPF 1 Month Chart | chartguy89 | investorshangout | 03/07/2014 10:41:29 PM |
chartguy89: HKMPF Stock Charts Last: +0.5937 Wednesday, February 26, 2014 at 8:05:59 PM $HKMPF | chartguy89 | investorshangout | 02/27/2014 1:06:10 AM |
News, Short Squeeze, Breakout and More Instantly...
Hikma Pharmaceuticals Plc Company Name:
HKMPF Stock Symbol:
OTCMKTS Market:
Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals Canada NewsWire LONDON , April 29, 2022 /CNW/ -- Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary ...
Hikma resumes launch of generic Advair Diskus® PR Newswire LONDON , April 20, 2021 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that it has resumed the launch of its generic version of ...
LONDON , Sept. 3, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that the US Court of Appeals for the Federal Circuit today upheld a ruling by the US District Court for the District of Nevada finding that Hikma's gen...